Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort ascending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort ascending Date Posted
Legal Trainee – Research & Development and Innovative Medicines Basel (City) Switzerland Legal Innovative Medicines Others Oct 22, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Oct 10, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others May 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) France Innovative Medicines Others May 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others May 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Jun 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) France People & Organization Innovative Medicines Others Jul 04, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Aug 19, 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others Oct 22, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Utd.Arab Emir. Operations Innovative Medicines Others Oct 14, 2024
Embrace Advisor Verona Field Force (Italy) Italy International Innovative Medicines Others Oct 16, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Jul 22, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Sep 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Sep 26, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Sep 27, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Jun 20, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Jul 03, 2024
SAP Security Manager Prague Czech Republic Operations CTS Audit & Finance Jul 22, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Jul 05, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit & Finance Jul 17, 2024
BPA Planning Process, RLT Baarle Nassau Netherlands Finance Innovative Medicines Audit & Finance Aug 05, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Oct 15, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic